Literature DB >> 30935318

Antiepileptic Drugs to Prevent Seizures After Spontaneous Intracerebral Hemorrhage.

Federico Angriman1,2, Bharath Kumar Tirupakuzhi Vijayaraghavan1,3, Laura Dragoi1, Carmen Lopez Soto1,4, Martin Chapman1, Damon C Scales1,5.   

Abstract

Background and Purpose- We sought to evaluate the available literature to determine whether primary seizure prevention with antiepileptic drugs reduces the risk of poor outcomes and clinically relevant seizures among adult patients with spontaneous intracerebral hemorrhage. Methods- Meta-analysis of observational studies and randomized controlled trials evaluating the use of any antiepileptic drug for primary seizure prevention among adult (≥18 years) patients with spontaneous intracerebral hemorrhage. The primary end point was poor clinical outcome at the longest recorded follow-up, defined as either a high (>3) modified Rankin Scale score or all-cause mortality during follow-up if the modified Rankin Scale score was not recorded. Early and late seizures were secondary outcomes. A random mixed effects model was used to estimate the pooled odds ratio of outcomes and associated 95% CI. Results- We identified 7 studies with a total of 3241 patients for analysis of the primary outcome and 4 studies with a total of 1861 patients for analysis of the secondary outcomes. Overall, the use of antiepileptic drugs was not associated with a high Rankin Scale or all-cause mortality (odds ratio: 0.99; 95% CI, 0.66-1.49) or incident seizures (odds ratio: 0.89; 95% CI, 0.52-1.51) at the longest recorded follow-up time. Conclusions- The use of antiepileptic drugs as primary prevention among adult patients with spontaneous intracerebral hemorrhage is not associated with improved neurological function during long-term follow-up. Future studies should focus on the preventive use of distinct antiepileptic agents among patients at high risk of both seizures and poor outcomes.

Entities:  

Keywords:  anticonvulsants; cerebral hemorrhage; epilepsy; mortality; seizures

Mesh:

Substances:

Year:  2019        PMID: 30935318     DOI: 10.1161/STROKEAHA.118.024380

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Seizures and epilepsy after intracerebral hemorrhage: an update.

Authors:  Laurent Derex; Sylvain Rheims; Laure Peter-Derex
Journal:  J Neurol       Date:  2021-02-10       Impact factor: 4.849

2.  Relationship Between Mortality and Seizures After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Authors:  Hong-Yu Lin; Qing-Qing Wei; Jian-Yi Huang; Xing-Hua Pan; Ning-Chao Liang; Cai-Xia Huang; Teng Long; Wen Gao; Sheng-Liang Shi
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

Review 3.  Antiepileptic drugs for the primary and secondary prevention of seizures after stroke.

Authors:  Richard S Chang; William Cy Leung; Michael Vassallo; Lucy Sykes; Emma Battersby Wood; Joseph Kwan
Journal:  Cochrane Database Syst Rev       Date:  2022-02-07

4.  Hypothermia Induced by Oxcarbazepine after Transient Forebrain Ischemia Exerts Therapeutic Neuroprotection through Transient Receptor Potential Vanilloid Type 1 and 4 in Gerbils.

Authors:  Hyung-Il Kim; Jae-Chul Lee; Dae Won Kim; Myoung Cheol Shin; Jun Hwi Cho; Ji Hyeon Ahn; Soon-Sung Lim; Il Jun Kang; Joon Ha Park; Moo-Ho Won; Tae-Kyeong Lee
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

5.  Association Between Partial Pressure of Carbon Dioxide and Immediate Seizures in Patients With Primary Intracerebral Hemorrhage: A Propensity-Matched Analysis.

Authors:  Zhiming Pan; Qiuli Zhong; Chaoying Wang; Jianqun Wang; Xiaoyan Chen; Xiaoyan Li; Xintong Zhang; Yibin Zhang
Journal:  Front Neurol       Date:  2022-04-21       Impact factor: 4.003

6.  Antiepileptogenesis and disease modification: Clinical and regulatory issues.

Authors:  Jacqueline A French; Martina Bebin; Marc A Dichter; Jerome Engel; Adam L Hartman; Sergiusz Jóźwiak; Pavel Klein; James McNamara; Roy Twyman; Paul Vespa
Journal:  Epilepsia Open       Date:  2021-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.